Suppr超能文献

泛素化和蛋白酶体介导的polo样激酶降解

Ubiquitination and proteasome mediated degradation of polo-like kinase.

作者信息

Ferris D K, Maloid S C, Li C C

机构信息

Intramural Research Support Program, SAIC Frederick, Frederick, Maryland, 21702-1201, USA.

出版信息

Biochem Biophys Res Commun. 1998 Nov 18;252(2):340-4. doi: 10.1006/bbrc.1998.9648.

Abstract

Polo-like kinase (Plk) is a cell cycle-regulated, cyclin-independent serine/threonine protein kinase. Plk protein levels are low or undetectable in terminally differentiated cells and tissues and its expression is strongly correlated with cell growth. Plk protein and enzymatic activity are regulated by multiple mechanisms during cell cycle progression. During G1 Plk levels are low but increasing amounts of protein are detected during S phase and the highest amounts during G2M. Transcription of Plk message is specifically repressed during G1 but that cannot entirely account for the rapid disappearance of Plk protein at the end of mitosis. In this report we show that Plk protein can be degraded in vitro by partially purified proteasomes and that specific proteasome inhibitors can block Plk protein degradation both in vitro and in vivo. We also detected high molecular weight polyubiquitinated forms of Plk by immunoprecipitation and immunoblotting and confirmed that Plk, like other mitotic regulators, is targeted for destruction at the end of mitosis through the ubiquitin-proteasome mediated degradation pathway.

摘要

Polo样激酶(Plk)是一种细胞周期调控的、不依赖细胞周期蛋白的丝氨酸/苏氨酸蛋白激酶。在终末分化的细胞和组织中,Plk蛋白水平较低或无法检测到,其表达与细胞生长密切相关。在细胞周期进程中,Plk蛋白和酶活性受多种机制调控。在G1期,Plk水平较低,但在S期可检测到蛋白量增加,在G2/M期蛋白量最高。Plk信使RNA的转录在G1期受到特异性抑制,但这并不能完全解释有丝分裂末期Plk蛋白的快速消失。在本报告中,我们表明Plk蛋白可在体外被部分纯化的蛋白酶体降解,并且特异性蛋白酶体抑制剂可在体外和体内阻断Plk蛋白的降解。我们还通过免疫沉淀和免疫印迹检测到高分子量的多聚泛素化形式的Plk,并证实Plk与其他有丝分裂调节因子一样,在有丝分裂末期通过泛素-蛋白酶体介导的降解途径被靶向破坏。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验